<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01334840</url>
  </required_header>
  <id_info>
    <org_study_id>BW-09</org_study_id>
    <nct_id>NCT01334840</nct_id>
  </id_info>
  <brief_title>Mechanism of Action of Vichy Catalan Water</brief_title>
  <official_title>Mechanism of Action of Vichy Catalan Water</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Research Council, Spain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Vichy Catalán, Spain</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Research Council, Spain</source>
  <brief_summary>
    <textblock>
      Water consumption is essential to maintain hydration and good health. Sodium-bicarbonated
      mineral waters are reported to have beneficial digestive and hypocholesterolemic properties.
      The aim of this study was to investigate the effects of the consumption of a
      sodium-bicarbonated mineral water (BW) with or without a meal, compared to a low mineral
      content water as a control water (CW), on postprandial serum triacylglycerols (TAG),
      cholecystokinin (CCK), and gallbladder volume.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">July 2010</completion_date>
  <primary_completion_date type="Actual">May 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum triacylglycerols</measure>
    <time_frame>Baseline</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum triacylglycerols</measure>
    <time_frame>Postprandial 30 minutes</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum triacylglycerols</measure>
    <time_frame>Postprandial 60 minutes</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum triacylglycerols</measure>
    <time_frame>Postprandial 120 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum glucose</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum glucose</measure>
    <time_frame>Postprandial 30 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum glucose</measure>
    <time_frame>Postprandial time 60 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum glucose</measure>
    <time_frame>Postprandial time 120 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum insulin</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum insulin</measure>
    <time_frame>Postprandial 30 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum insulin</measure>
    <time_frame>Postprandial 60 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum insulin</measure>
    <time_frame>Postprandial 120 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cholecystokinin</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cholecystokinin</measure>
    <time_frame>Postprandial 30 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cholecystokinin</measure>
    <time_frame>Postprandial 60 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cholecystokinin</measure>
    <time_frame>Postprandial 120 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gallbladder volume</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gallbladder volume</measure>
    <time_frame>Postprandial 15 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gallbladder volume</measure>
    <time_frame>Postprandial 30 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gallbladder volume</measure>
    <time_frame>Postprandial 60 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gallbladder volume</measure>
    <time_frame>Postprandial 120 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aldosterone</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aldosterone</measure>
    <time_frame>Postprandial 30 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aldosterone</measure>
    <time_frame>Postprandial 60 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aldosterone</measure>
    <time_frame>Postprandial 120 minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <arm_group>
    <arm_group_label>BW</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bicarbonated mineral water without meal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BW with meal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bicarbonated mineral water with meal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CW</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Mineral water low in mineral content (control) without meal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CW with meal</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Mineral water low in mineral content (control) with a meal</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Bicarbonated mineral water</intervention_name>
    <description>Volunteers fasted overnight consumed:
0.5 L of the bicarbonated mineral water without meal or, 0.5 L of the bicarbonated mineral water with meal</description>
    <arm_group_label>BW</arm_group_label>
    <arm_group_label>BW with meal</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Mineral water low in mineral content (control)</intervention_name>
    <description>Volunteers fasted overnight consumed:
0.5 L of the control water without meal or, 0.5 L of the control water with meal</description>
    <arm_group_label>CW</arm_group_label>
    <arm_group_label>CW with meal</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult (&gt;18 and &lt;40 years)

          -  BMI &gt;18 and &lt;30 kg/m2

        Exclusion Criteria:

          -  Age &lt;18 and &gt; 40 years

          -  TAG &gt; 250 mg/dL (2.82 mmol/L)

          -  Being a usual consumer of carbonic mineral water

          -  Obesity

          -  Diabetes

          -  Hypertension or digestive, liver and renal disease

          -  Biliary obstruction

          -  Eating disorders

          -  Being under medication that could affect lipid metabolism

          -  Consumption of functional foods that could affect lipid metabolism (food containing
             n-3 fatty acids or phytosterols)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>M Pilar Vaquero, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Research Council, Spain</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institute of Food Science, Technology and Nutrition (ICTAN), Spanish National Research Council (CISC)</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Schoppen S, Pérez-Granados AM, Carbajal A, Oubiña P, Sánchez-Muniz FJ, Gómez-Gerique JA, Vaquero MP. A sodium-rich carbonated mineral water reduces cardiovascular risk in postmenopausal women. J Nutr. 2004 May;134(5):1058-63.</citation>
    <PMID>15113945</PMID>
  </reference>
  <reference>
    <citation>Schoppen S, Pérez-Granados AM, Carbajal A, de la Piedra C, Pilar Vaquero M. Bone remodelling is not affected by consumption of a sodium-rich carbonated mineral water in healthy postmenopausal women. Br J Nutr. 2005 Mar;93(3):339-44.</citation>
    <PMID>15877873</PMID>
  </reference>
  <reference>
    <citation>Schoppen S, Pérez-Granados AM, Carbajal A, Sarriá B, Sánchez-Muniz FJ, Gómez-Gerique JA, Pilar Vaquero M. Sodium bicarbonated mineral water decreases postprandial lipaemia in postmenopausal women compared to a low mineral water. Br J Nutr. 2005 Oct;94(4):582-7.</citation>
    <PMID>16197584</PMID>
  </reference>
  <reference>
    <citation>Schoppen S, Pérez-Granados AM, Carbajal A, Sarriá B, Navas-Carretero S, Pilar Vaquero M. Sodium-bicarbonated mineral water decreases aldosterone levels without affecting urinary excretion of bone minerals. Int J Food Sci Nutr. 2008 Jun;59(4):347-55.</citation>
    <PMID>17886090</PMID>
  </reference>
  <reference>
    <citation>Schoppen S, Sánchez-Muniz FJ, Pérez-Granados M, Gómez-Gerique JA, Sarriá B, Navas-Carretero S, Pilar Vaquero M. Does bicarbonated mineral water rich in sodium change insulin sensitivity of postmenopausal women? Nutr Hosp. 2007 Sep-Oct;22(5):538-44.</citation>
    <PMID>17970536</PMID>
  </reference>
  <reference>
    <citation>Pérez-Granados AM, Navas-Carretero S, Schoppen S, Vaquero MP. Reduction in cardiovascular risk by sodium-bicarbonated mineral water in moderately hypercholesterolemic young adults. J Nutr Biochem. 2010 Oct;21(10):948-53. doi: 10.1016/j.jnutbio.2009.07.010. Epub 2009 Dec 1.</citation>
    <PMID>19954956</PMID>
  </reference>
  <reference>
    <citation>Schoppen S, Pérez-Granados AM, Navas-Carretero S, Vaquero MP. Postprandial lipaemia and endothelial adhesion molecules in pre- and postmenopausal Spanish women. Nutr Hosp. 2010 Mar-Apr;25(2):256-61.</citation>
    <PMID>20449535</PMID>
  </reference>
  <results_reference>
    <citation>Toxqui L, Pérez-Granados AM, Blanco-Rojo R, Vaquero MP. A sodium-bicarbonated mineral water reduces gallbladder emptying and postprandial lipaemia: a randomised four-way crossover study. Eur J Nutr. 2012 Aug;51(5):607-14. doi: 10.1007/s00394-011-0244-x. Epub 2011 Sep 13.</citation>
    <PMID>21913027</PMID>
  </results_reference>
  <results_reference>
    <citation>Toxqui L, Pérez-Granados AM, Blanco-Rojo R, Vaquero MP. Effects of an alkaline mineral water on cholecystokinin levels and gallbladder emptying in young adults. Ann Nutr Metab 58(suppl 3):352-353,2011</citation>
  </results_reference>
  <results_reference>
    <citation>Toxqui L, Pérez-Granados AM, Blanco-Rojo R, Vaquero MP. Sodium-bicarbonated mineral water reduces postprandial lipaemia in moderately hypercholesterolaemic young adults. Proceedings of the Nutrition Society 70 (OCE4):E245, 2011.</citation>
  </results_reference>
  <verification_date>April 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 12, 2011</study_first_submitted>
  <study_first_submitted_qc>April 12, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 13, 2011</study_first_posted>
  <last_update_submitted>July 29, 2014</last_update_submitted>
  <last_update_submitted_qc>July 29, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 30, 2014</last_update_posted>
  <responsible_party>
    <name_title>M Pilar Vaquero</name_title>
    <organization>National Research Council, Spain</organization>
  </responsible_party>
  <keyword>Cardiovascular risk</keyword>
  <keyword>Cholecystokinin</keyword>
  <keyword>Gallbladder emptying</keyword>
  <keyword>Lipid absorption</keyword>
  <keyword>Postprandial triacylglycerols</keyword>
  <keyword>Sodium-bicarbonated mineral water</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

